Jansen JH - Search Results

1

Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes.

Nikoloski G, Langemeijer SM, Kuiper RP, Knops R, Massop M, Tönnissen ER, van der Heijden A, Scheele TN, Vandenberghe P, de Witte T, van der Reijden BA, Jansen JH. Nikoloski G, et al. Among authors: jansen jh. Nat Genet. 2010 Aug;42(8):665-7. doi: 10.1038/ng.620. Epub 2010 Jul 4. Nat Genet. 2010. PMID: 20601954

2

Acute leukemias with structurally altered core binding factor subunits (t(8;21), inv(16), t(12;21)), 27-28 June 1997, Rotterdam, The Netherlands.

van der Reijden BA, Bloomfield CD, Touw IP, Jansen JH. van der Reijden BA, et al. Among authors: jansen jh. Leukemia. 1997 Dec;11(12):2217-9. Leukemia. 1997. PMID: 9447846

3

TRIADs: a new class of proteins with a novel cysteine-rich signature.

van der Reijden BA, Erpelinck-Verschueren CA, Löwenberg B, Jansen JH. van der Reijden BA, et al. Among authors: jansen jh. Protein Sci. 1999 Jul;8(7):1557-61. doi: 10.1110/ps.8.7.1557. Protein Sci. 1999. PMID: 10422847 Free PMC article.

4

Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-676).

de Vetten MP, Jansen JH, van der Reijden BA, Berger MS, Zijlmans JM, Löwenberg B. de Vetten MP, et al. Among authors: jansen jh. Br J Haematol. 2000 Oct;111(1):277-9. doi: 10.1046/j.1365-2141.2000.02402.x. Br J Haematol. 2000. PMID: 11091212 Free article.

5

Degradable dU-based DNA template as a standard in real-time PCR quantitation.

Pennings JL, Van De Locht LT, Jansen JH, Van der Reijden BA, De Witte T, Mensink EJ. Pennings JL, et al. Among authors: jansen jh. Leukemia. 2001 Dec;15(12):1962-5. doi: 10.1038/sj.leu.2402290. Leukemia. 2001. PMID: 11753618

6

Acquired skewing of Lyonization remains stable for a prolonged period in healthy blood donors.

van Dijk JP, Heuver L, Stevens-Linders E, Jansen JH, Mensink EJ, Raymakers RA, de Witte T. van Dijk JP, et al. Among authors: jansen jh. Leukemia. 2002 Mar;16(3):362-7. doi: 10.1038/sj.leu.2402379. Leukemia. 2002. PMID: 11896539

7

Identification of a novel CBFB-MYH11 transcript: implications for RT-PCR diagnosis.

Van der Reijden BA, de Wit L, van der Poel S, Luiten EB, Lafage-Pochitaloff M, Dastugue N, Gabert J, Löwenberg B, Jansen JH. Van der Reijden BA, et al. Among authors: jansen jh. Hematol J. 2001;2(3):206-9. doi: 10.1038/sj.thj.6200103. Hematol J. 2001. PMID: 11920247

8

Bcl-2 protects against apoptosis induced by antimycin A and bongkrekic acid without restoring cellular ATP levels.

de Graaf AO, Meijerink JP, van den Heuvel LP, DeAbreu RA, de Witte T, Jansen JH, Smeitink JA. de Graaf AO, et al. Among authors: jansen jh. Biochim Biophys Acta. 2002 Apr 22;1554(1-2):57-65. doi: 10.1016/s0005-2728(02)00213-x. Biochim Biophys Acta. 2002. PMID: 12034471 Free article.

9

Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.

van der Reijden BA, Simons A, Luiten E, van der Poel SC, Hogenbirk PE, Tönnissen E, Valk PJ, Löwenberg B, De Greef GE, Breuning MH, Jansen JH. van der Reijden BA, et al. Among authors: jansen jh. Br J Haematol. 2002 Aug;118(2):411-8. doi: 10.1046/j.1365-2141.2002.03738.x. Br J Haematol. 2002. PMID: 12139724 Free article.

10

Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.

Van Dijk JP, Knops GH, Van De Locht LT, Menke AL, Jansen JH, Mensink EJ, Raymakers RA, De Witte T. Van Dijk JP, et al. Among authors: jansen jh. Br J Haematol. 2002 Sep;118(4):1027-33. doi: 10.1046/j.1365-2141.2002.03728.x. Br J Haematol. 2002. PMID: 12199781 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

314 results

Search Page

Filters